GlassScriptPhysician profile
Melanie Gossard
NPI 1255807335
$830.17
in general payments reported to CMS, 2019-2025
11 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $233 · 2023: $254 · 2024: $148 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $380.89 | 2022-2025 | Collagenase Santyl, Renasys Go V2 Home, Regranex |
| Organogenesis INC. | $197.82 | 2023-2025 | Puraply, Affinity, Apligraf |
| Bsn Medical INC | $55.53 | 2022 | |
| Molnlycke Health Care US, LLC | $51.60 | 2024-2025 | Mepilex Border Flex, Mextra Superabsorbant, Exufiber Ag+ |
| Solventum Corporation | $34.01 | 2024 | Activ.A.C. |
| Kerecis Limited | $29.88 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $20.24 | 2023 | Nuzyra |
| Hartmann USA, INC. | $19.78 | 2024 | Colactive Plus 2x2 |
| Mimedx Group, INC. | $13.59 | 2025 | |
| Reddress USA, INC. | $13.53 | 2023 | |
| Ovik Health, LLC | $13.30 | 2024 | Agile |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Gossard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.